Business briefs: Layoffs at Roche and Merck, plus pipeline news

Merck and Roche Diagnostics announce job cuts; Novartis abandons an Afinitor study; an FDA advisory committee gives Bayer's lung drug the nod; Vivus still has no plans for Qsymia DTC; and Isis drops development of a mid-stage RA drug

Reimagining healthcare? We want to hear about it.
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters